VYCOR MEDICAL INC (VYCO) › Cost of RevenueVYCOR MEDICAL INC (VYCO) — Cost of RevenueAnnual figures by period end, from SEC filings.2017-12-31: $227.1K2018-12-31: $169.6K2019-12-31: $134.8K2020-12-31: $132.5K2021-12-31: $134.7K2022-12-31: $140.6K2023-12-31: $144.9K2024-12-31: $166.8K2025-12-31: $302.3K$302.3K2017-12-31Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$302.3K+81.2%2026-03-31From 2025-01-012024-12-31$166.8K+15.1%2026-03-31From 2024-01-012023-12-31$144.9K+3.1%2025-04-15From 2023-01-012022-12-31$140.6K+4.4%2024-04-16From 2022-01-012021-12-31$134.7K+1.7%2023-04-14From 2021-01-012020-12-31$132.5K-1.7%2022-04-13From 2020-01-012019-12-31$134.8K-20.5%2021-03-31From 2019-01-012018-12-31$169.6K-25.3%2020-03-27From 2018-01-012017-12-31$227.1K—2019-03-29From 2017-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)